267 related articles for article (PubMed ID: 20233272)
1. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of different beta-blockers in the treatment of long QT syndrome.
Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
[TBL] [Abstract][Full Text] [Related]
3. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.
Hobbs JB; Peterson DR; Moss AJ; McNitt S; Zareba W; Goldenberg I; Qi M; Robinson JL; Sauer AJ; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Towbin JA; Vincent GM; Zhang L
JAMA; 2006 Sep; 296(10):1249-54. PubMed ID: 16968849
[TBL] [Abstract][Full Text] [Related]
4. Advice for management of the long-QT patient.
Donahue JK
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):902-4. PubMed ID: 20455972
[No Abstract] [Full Text] [Related]
5. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
[TBL] [Abstract][Full Text] [Related]
8. Risk of fatal arrhythmic events in long QT syndrome patients after syncope.
Jons C; Moss AJ; Goldenberg I; Liu J; McNitt S; Zareba W; Qi M; Robinson JL
J Am Coll Cardiol; 2010 Feb; 55(8):783-8. PubMed ID: 20170817
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.
Ahn J; Kim HJ; Choi JI; Lee KN; Shim J; Ahn HS; Kim YH
PLoS One; 2017; 12(10):e0185680. PubMed ID: 29059199
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients.
Biton Y; Rosero S; Moss AJ; Goldenberg I; Kutyifa V; McNitt S; Polonsky B; Baman JR; Zareba W
Europace; 2019 Feb; 21(2):339-346. PubMed ID: 29947754
[TBL] [Abstract][Full Text] [Related]
12. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
[TBL] [Abstract][Full Text] [Related]
13. Risk of death in the long QT syndrome when a sibling has died.
Kaufman ES; McNitt S; Moss AJ; Zareba W; Robinson JL; Hall WJ; Ackerman MJ; Benhorin J; Locati ET; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
Heart Rhythm; 2008 Jun; 5(6):831-6. PubMed ID: 18534367
[TBL] [Abstract][Full Text] [Related]
14. Long QT syndrome and pregnancy.
Seth R; Moss AJ; McNitt S; Zareba W; Andrews ML; Qi M; Robinson JL; Goldenberg I; Ackerman MJ; Benhorin J; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
J Am Coll Cardiol; 2007 Mar; 49(10):1092-8. PubMed ID: 17349890
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome.
Goldenberg I; Moss AJ; Peterson DR; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Priori SG; Qi M; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
Circulation; 2008 Apr; 117(17):2184-91. PubMed ID: 18427136
[TBL] [Abstract][Full Text] [Related]
16. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.
Zareba W; Moss AJ; Schwartz PJ; Vincent GM; Robinson JL; Priori SG; Benhorin J; Locati EH; Towbin JA; Keating MT; Lehmann MH; Hall WJ
N Engl J Med; 1998 Oct; 339(14):960-5. PubMed ID: 9753711
[TBL] [Abstract][Full Text] [Related]
17. Syncope in genotype-negative long QT syndrome family members.
Olde Nordkamp LR; Ruwald MH; Goldenberg I; Wieling W; McNitt S; Polonsky B; Wilde AA; van Dijk N; Moss AJ
Am J Cardiol; 2014 Oct; 114(8):1223-8. PubMed ID: 25173441
[TBL] [Abstract][Full Text] [Related]
18. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.
Migdalovich D; Moss AJ; Lopes CM; Costa J; Ouellet G; Barsheshet A; McNitt S; Polonsky S; Robinson JL; Zareba W; Ackerman MJ; Benhorin J; Kaufman ES; Platonov PG; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Goldenberg I
Heart Rhythm; 2011 Oct; 8(10):1537-43. PubMed ID: 21440677
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines.
Sundström E; Jensen SM; Diamant UB; Rydberg A
Scand Cardiovasc J; 2017 Apr; 51(2):88-94. PubMed ID: 27936942
[TBL] [Abstract][Full Text] [Related]
20. Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome.
Extramiana F; Maison-Blanche P; Denjoy I; De Jode P; Messali A; Labbé JP; Leenhardt A
Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):399-408. PubMed ID: 23879280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
